Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-060510

Options or other derivatives

  • President & CEO acquired 167,650 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-12 Grant or award : show line 1 in the form Stock Option +167,650 167,650 D
Loading xslF345X03/doc4.xml…